GENE - Genetic Technologies Limited

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 512.25M
Enterprise Value 312.34M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.55
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-66.90%
Return on Equity (ttm)-102.16%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)-81.20%
Gross Profit (ttm)-110.83k
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.3000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.99
Book Value Per Share (mrq)0.15

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 4.53
52-Week Change 3-40.17%
S&P500 52-Week Change 34.92%
52 Week High 32.0400
52 Week Low 30.5100
50-Day Moving Average 30.8580
200-Day Moving Average 30.8693

Share Statistics

Avg Vol (3 month) 3988.86k
Avg Vol (10 day) 3915.8k
Shares Outstanding 52.54B
Float 14.4M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Apr 30, 2019) 4185.56k
Short Ratio (Apr 30, 2019) 45.17
Short % of Float (Apr 30, 2019) 4N/A
Short % of Shares Outstanding (Apr 30, 2019) 41.06%
Shares Short (prior month Mar 29, 2019) 4191.01k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 25/1
Last Split Date 3Jan 20, 2015